Clinical and serological prognostic markers in primary biliary cholangitis
- PMID: 33752318
- PMCID: PMC8046621
- DOI: 10.3350/cmh.2021.0088
Clinical and serological prognostic markers in primary biliary cholangitis
Keywords: Anti-gp-210 antibodies; Antibodies, Antinuclear; Cirrhosis; Primary biliary cholangitis; Prognosis.
Conflict of interest statement
The author has no conflicts of interest to disclose.
Comment on
-
Current understanding of primary biliary cholangitis.Clin Mol Hepatol. 2021 Jan;27(1):1-21. doi: 10.3350/cmh.2020.0028. Epub 2020 Dec 3. Clin Mol Hepatol. 2021. PMID: 33264835 Free PMC article. Review.
References
-
- Quarneti C, Muratori P, Lalanne C, Fabbri A, Menichella R, Granito A, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int. 2015;35:636–641. - PubMed
-
- Carbone M, Mells GF, Pells G, Dawwas MF, Newton JL, Heneghan MA, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013;144:560–569.e7. quiz e13-e14. - PubMed
-
- Granito A, Muratori P, Quarneti C, Pappas G, Cicola R, Muratori L. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn. 2012;12:65–74. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
